TELA BIO INC's ticker is TELA and the CUSIP is 872381108. A total of 68 filers reported holding TELA BIO INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,808,024 | -11.3% | 976,003 | +12.4% | 0.00% | – |
Q2 2023 | $8,798,098 | +16.4% | 868,519 | +22.3% | 0.00% | – |
Q1 2023 | $7,558,305 | -2.7% | 710,367 | +5.2% | 0.00% | – |
Q4 2022 | $7,765,203 | +132.8% | 675,235 | +72.4% | 0.00% | – |
Q3 2022 | $3,336,000 | +21.5% | 391,568 | 0.0% | 0.00% | – |
Q2 2022 | $2,745,000 | -39.7% | 391,568 | 0.0% | 0.00% | – |
Q1 2022 | $4,554,000 | +2.3% | 391,568 | +12.5% | 0.00% | – |
Q4 2021 | $4,453,000 | -7.9% | 347,935 | -1.7% | 0.00% | – |
Q3 2021 | $4,836,000 | -12.3% | 353,969 | +3.4% | 0.00% | – |
Q2 2021 | $5,514,000 | -11.8% | 342,280 | -18.4% | 0.00% | – |
Q1 2021 | $6,251,000 | +4.2% | 419,520 | +5.2% | 0.00% | – |
Q4 2020 | $5,998,000 | -11.4% | 398,799 | -2.5% | 0.00% | – |
Q3 2020 | $6,766,000 | +115.1% | 409,048 | +68.5% | 0.00% | – |
Q2 2020 | $3,145,000 | +704.3% | 242,692 | +385.4% | 0.00% | – |
Q1 2020 | $391,000 | -39.6% | 50,000 | 0.0% | 0.00% | – |
Q4 2019 | $647,000 | – | 50,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 3,565,709 | $24,996,000 | 10.33% |
Opaleye Management Inc. | 1,643,367 | $11,520,000 | 5.19% |
INDUSTRY VENTURES, L.L.C. | 579,745 | $4,064,000 | 4.31% |
Velan Capital Investment Management LP | 498,238 | $3,493,000 | 3.54% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 116,095 | $825,000 | 0.83% |
HAMILTON LANE ADVISORS LLC | 264,366 | $1,853,000 | 0.72% |
AIGH Capital Management LLC | 306,464 | $2,156,000 | 0.57% |
Worth Venture Partners, LLC | 113,012 | $904,000 | 0.53% |
Granite Point Capital Management, L.P. | 227,644 | $1,596,000 | 0.41% |
Orbimed Advisors | 3,027,542 | $21,223,000 | 0.38% |